Web Results

Sanofi-Aventis Deutschland GmbH v. Glenmark Pharmaceuticals Inc ...

www.oliff.com/wp-content/uploads/2012/03/2012-1489-Court.pdf

SANOFI-AVENTIS DEUTSCHLAND v. ... sively licensed to Sanofi-Aventis Deutschland GmbH (a company ..... The district court found that litigation became “rea-.

Patent Docs: Sanofi-Aventis Deutschland GmbH v. Glenmark ...

www.patentdocs.org/2014/04/sanofi-aventis-deutschland-gmbh-v-glenmark-pharmaceuticals-inc-fed-cir-2014.html

Apr 24, 2014 ... Sanofi On April 21, 2014, a Federal Circuit panel reiterated its interpretation and application to the chemical arts of the KSR obviousness ...

Federal Circuit Year in Review 2013/2014 - Gibson Dunn

www.gibsondunn.com/publications/Documents/Federal-Circuit-2013-2014-Year-in-Review.pdf

claim construction rulings, following last year's decision in Teva v. Sandoz, which is ... Accenture Global Servs., GMBH v. ...... 129. Rambus Inc. v. Rea,. 731 F.3d 1248, 2013 WL 5312505 (Fed. Cir. Sept. .... Sanofi-Aventis Deutschland GmbH v.

27 August 2015: 20+ years post-TRIPS – are submarines still out ...

www.reddie.co.uk/news-and-resources/ip-developments/twenty-years-post-trips-are-submarines-still-out-there

Aug 27, 2015 ... A letter from Teresa Rea (see pages 231-244), then Acting Director of the ... Smokeless Tobacco Company, Sanofi-Aventis Deutschland GmbH ...

IP @ Ashurst - Quarterly Edition

www.ashurst.com/doc.aspx?id_Content=9919

Dec 4, 2013 ... REA Group Ltd v Real Estate 1 Ltd (No 2) [2013] FCA 968. Following the .... Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Australia.

and Post-KSR Analysis

www.ipo.org/wp-content/uploads/2013/03/Spennerarticle.pdf

A. Sanofi-Synthe/abo v. ..... 17 ld. at 57; Aventis Pharma Deutschland GmbH v. ... 19 ld.; Aventis, 499 F.3d at 1295 ("A stereoisomer is an isomer in which the same atoms are bonded to the same ..... dictability decreases --as well as any rea-.

William E. Solander | Attorney | Fitzpatrick, Cella, Harper & Scinto ...

www.fitzpatrickcella.com/?t=3&A=2207&format=xml&p=2429

Some of the companies that he has represented or advised include Debiopharm, Grunenthal, Ikaria, LEO Pharma, Mars, Merck, Novartis, Sanofi and Sunovion.

Pharmaceuticals | Industry Detail | Fitzpatrick, Cella, Harper & Scinto ...

www.fitzpatrickcella.com/?t=38&I=526&format=xml&p=4713

... Astellas, AstraZeneca, Bausch & Lomb, Bristol-Myers Squibb, Daiichi Sankyo, Genzyme, Kyowa Hakko, Merck, Novartis, Sepracor, Sanofi-Aventis and UCB.

Analysis of Antibody Aggregate Content at Extremely High ... - Plos

journals.plos.org/plosone/article/asset?id=10.1371/journal.pone.0120820.PDF

Mar 24, 2015 ... Funding: Sanofi-Aventis Deutschland GmbH ordered and paid ... For these rea- .... vs. 1.75 in the XL-I centrifuge after adapting the lens system ...

View All - Federal Circuit Court Decisions | Finnegan

www.finnegan.com/publications/federalcircuit/FederalCircuitCourtLanding.aspx?viewallsummarized=View only cases summarized by Finnegan&KeywordPhrase=&p=all

Intendis GMBH v. Glenmark ...... Sanofi-Aventis Deutschland v. Glenmark .... Summary icon Summary. 08/12/2013. Leo Pharmaceutical Products v. Rea. 12- 1520.

More Info

Federal Circuit Patent Bulletin: Sanofi-Aventis Deutschland GmbH v ...

www.wileyrein.com

Apr 21, 2014 ... On April 21, 2014, in Sanofi-Aventis Deutschland GmbH v. Glenmark Pharms. Inc ., USA, the U.S. Court of Appeals for the Federal Circuit ...

Steptoe & Johnson LLP: Federal Circuit Representative Matters

www.steptoe.com

Randall Mfg. v. Rea (Fed. Cir. 2013) – Counsel for appellant Randall Mfg. in ... Innovative Biometric Technologies v. ... Sanofi-Aventis Deutschland GmbH v.

Bristol-Myers Squibb Co. v. Teva Pharm. USA, Inc. - Chinese ...

chineseip.jmls.edu

Oct 20, 2014 ... BRISTOL-MYERS SQUIBB COMPANY V. .... See Sanofi-Aventis Deutschland GmbH v. Glenmark Pharm., Inc., 748 F.3d 1354, 1360 ... See Sanofi-Aventis, 748 F.3d at 1360. Apparently ...... Prods., Ltd. v. Rea, 726 F.3d 1346,.